An Evidence-Based Approach to Creating Realistic Development Timelines
RALEIGH, N.C., March 19 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces its Senior Vice President of Scientific and Medical Affairs, Kent Thoelke, will host a webinar on optimizing site and country selection. The webinar will take place on March 25, 2009 at 11:30 am ET.
Mr. Thoelke will discuss how to mitigate one of the greatest risks for successful drug development: delayed clinical development timelines. Detailed planning and appropriate site and country selection are the most critical factors in meeting target patient accrual goals within the planned timeline. Mr. Thoelke will explore how an evidence-based approach, coupled with survey based feasibility provides the most accurate forecast for patient accrual and the selection of sites and countries with the highest likelihood of being productive.
With PRA since 2006, Mr. Thoelke has over 19 years of experience in the global drug development and device industry, holding positions in both clinical and corporate development in multinational R&D companies, as well as small and emerging biotechnology companies. As part of the PRA Leadership Team, Mr. Thoelke provides high-level strategic oversight of product development, supporting PRA teams that are executing studies for Sponsors. Having visited over 40 countries, he is very familiar with the global drug development environment, and has established relationships with therapeutic experts in numerous indications around the world. Mr. Thoelke has spoken widely regarding the current landscape of clinical trial recruitment and its effect on drug development timelines. He is active in pursuing novel technologies and strategies to move the current clinical drug development paradigm away from anecdotal strategy to a more focused evidence-based strategy.
The deadline for registration is Tuesday March 24, 2009. Registration information can be found at: http://www.fxconferences.com/Beyond-Global-Feasibility-An-Evidence-Based-Approach-to-Creating-Realistic-Development-Timelines-P300.aspx .
About PRA International
PRA International is a global Clinical Research Organization providing services through all phases of clinical development. Although we specialize in Oncology, CNS, Respiratory/Allergy, Cardiovascular and Infectious Diseases, we perform studies in all therapeutic areas. PRA has supported over 2,100 clinical trials through its 35 global offices. PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge, enable our project teams to deliver consistent and on time performance for our clients.
|SOURCE PRA International|
Copyright©2009 PR Newswire.
All rights reserved